Federal Express Corp., known as FedEx, said Tuesday it won the “Best Logistics and Supply Chain Management” award in the “Last-Mile Implementation” category at the Asia-Pacific Biopharma Excellence Awards 2026.
The awards are hosted by IMAPAC, an international organization in the pharmaceutical and biotech sector. They recognize companies that have contributed to industry development in Asia across areas including bioprocessing, logistics, supply chain management and clinical research.
The Asia healthcare market is expected to expand to about $5 trillion by 2030, accounting for roughly 40% of the global healthcare market. The healthcare cold-chain logistics market is also projected to grow from about $31.9 billion last year to about $42.5 billion by 2031. With temperature control critical in healthcare, the role of logistics partners with integrated capabilities is growing, the company said.
“This award is a meaningful achievement that shows healthcare customers trust FedEx,” said Salil Chari, FedEx regional president for Asia Pacific. “As therapies become more specialized and temperature control becomes more important, logistics requirements are also increasing. FedEx will support safe transport based on systematic operational capabilities.”
FedEx said it supports stable transport across multiple temperature ranges, including ultra-low freezing below minus 70 degrees Celsius, freezing below minus 20 degrees, refrigerated shipments at 2 to 8 degrees, and controlled room temperature at 15 to 20 degrees. It has built a network of FedEx Life Science Center locations in Gimpo, South Korea; Memphis, Tennessee; Mumbai, India; Singapore; Tokyo; and Veldhoven, Netherlands.
The company said it operates more than 130 cold-chain facilities worldwide to maintain temperature control in cross-border, multimodal logistics. It also said 22 FedEx facilities worldwide are part of a network with CEIV Pharma certification for international air transport of pharmaceuticals, positioning FedEx as a key logistics partner for high-value healthcare shipments including biopharmaceuticals, vaccines, and cell and gene therapies.
* This article has been translated by AI.
Copyright ⓒ Aju Press All rights reserved.